🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: BPO gel

Found 34 matching trials

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

PHASE3

This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety...

Status

Completed

Location

Rady Children's Hospital San Diego, Div. of Pediatric & Adolescents Dermatology

Start Date

2008-10

Trial ID

NCT00776919

Treatments Being Tested

clindamycin / benzoyl peroxide gel clindamycin gel BPO gel vehicle gel

Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO

comparing the outcome of low-intensity shock wave therapy (Li-SWT) versus s...

Status

Completed

Location

Urology and Nephrology center

Start Date

2020-07-04

Trial ID

NCT04437108

Treatments Being Tested

Li-SWT (suprapubic approach)Li-SWT (perineal approach)Li-SWT (combined approach)Sham treatment Solifenacin

Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

PHASE3

The purpose of this study is to demonstrate the non-inferior efficacy of Ad...

Status

Completed

Location

Paul YAMAUCHI

Start Date

2007-02

Trial ID

NCT00441415

Treatments Being Tested

Adapalene BPO

Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne

PHASE3

This is a multicenter open-label, prospective study in subjects with dark s...

Status

Completed

Location

Dermresearch

Start Date

2017-02-02

Trial ID

NCT02932267

Treatments Being Tested

Adapalene 0.3% / BPO 2.5% gel

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

PHASE4

This is a single-blind (blinded expert grader) study that will enroll 25-30...

Status

Completed

Location

cyberDERM

Start Date

2009-08

Trial ID

NCT01015638

Treatments Being Tested

Clindamycin and BPO 5% gel Clindamycin phosphate and benzoyl peroxide 2.5% gel.

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

PHASE4

The purpose of this study is to assess subjects' experiences using Adapalen...

Status

Completed

Location

Thomas J. Stephens and Associates

Start Date

2010-10

Trial ID

NCT01209949

Treatments Being Tested

Adapalene 0.1% and Benzoyl Peroxide 2.5% gel

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

PHASE1

This study was conducted to determine if the bioavailability of clindamycin...

Status

Completed

Location

Multiple Locations

Start Date

2010-05-06

Trial ID

NCT01132443

Treatments Being Tested

Clindamycin 1%-Benzoyl Peroxide (BPO) 3% Gel,

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

PHASE3

Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl...

Status

Completed

Location

Alliance Dermatology

Start Date

2015-05

Trial ID

NCT02616614

Treatments Being Tested

Onexton Clindamycin/benzoyl peroxide gel Placebo

Experience With Topical Acne Treatment

EARLY_PHASE1

Acne is a chronic condition that typically requires the use of multiple med...

Status

Active Not Recruiting

Location

Wake Forest University Health Sciences

Start Date

2024-02-15

Trial ID

NCT05582434

Treatments Being Tested

clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

PHASE4

This is a randomized, half-face study. On 1 side of the face, the subject w...

Status

Completed

Location

cyberDERM

Start Date

2009-07

Trial ID

NCT00964366

Treatments Being Tested

clindamycin and benzoyl peroxide Dapsone gel

Previous Next